# Reliance Global Group, Inc.: Form 10-Q for the period ended Jun 30, 2025

- Company: [Reliance Global Group, Inc.](/companies/ezra.md) (CIK 1812727)
- Form: 10-Q
- Filed: 2025-07-30
- Accepted by EDGAR: Jul 30, 2025, 16:29 ET
- Period: 2025-06-30
- Accession: 0001641172-25-021555
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1812727/000164117225021555/form10-q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1812727/000164117225021555/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2025-04-01 to 2025-06-30 | $3.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2025-01-01 to 2025-06-30 | $7.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Operating income | 3 months, 2025-04-01 to 2025-06-30 | −$2.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2025-01-01 to 2025-06-30 | −$3.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 6 months, 2025-01-01 to 2025-06-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2025-04-01 to 2025-06-30 | −$2.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2025-01-01 to 2025-06-30 | −$4.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2025-04-01 to 2025-06-30 | −$0.85 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2025-01-01 to 2025-06-30 | −$1.53 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2025-04-01 to 2025-06-30 | −$0.85 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2025-01-01 to 2025-06-30 | −$1.53 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2025-04-01 to 2025-06-30 | 3,198,461 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2025-01-01 to 2025-06-30 | 2,907,209 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2025-01-01 to 2025-06-30 | −$654.7k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2025-01-01 to 2025-06-30 | $9.5k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2025-06-30 | $2.0m | us-gaap:Cash |
| Current assets | at 2025-06-30 | $7.1m | us-gaap:AssetsCurrent |
| Total assets | at 2025-06-30 | $18.0m | us-gaap:Assets |
| Current liabilities | at 2025-06-30 | $5.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2025-06-30 | $14.9m | us-gaap:Liabilities |
| Long-term debt | at 2025-06-30 | $8.6m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2025-06-30 | $1.7m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2025-06-30 | $106.2k | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2025-06-30 | $3.1m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 33,353 characters.

*You should read the following discussion and analysis of our financial condition and results of operations together with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q, as well as the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2024 (the “Annual Report”). Some of the information contained in this discussion and analysis or set forth elsewhere in this Quarterly Report on Form 10-Q, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks, uncertainties and assumptions. You should read the sections titled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors” in this Quarterly Report on Form 10-Q and in our Annual Report for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.*

### Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical fact contained in this report, including statements regarding our strategy, future financial condition, future operations, projected revenues, earnings, business prospects, potential acquisitions and plans, and objectives of management, are forward-looking statements. Words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and similar expressions are intended to identify such forward-looking statements.

These forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied by any forward-looking statements. These risks and uncertainties include, but are not limited to, the following:

- our need to raise additional capital, which may not be available on acceptable terms or at all;
- our ability to maintain the listing of our common stock and warrants on the Nasdaq Capital Market;
- volatility in the price of our securities due to changes in the capital markets, our industry, or our capital structure;
- our ability to execute on our acquisition strategy and integrate acquired businesses successfully;
- our ability to retain key personnel and effectively manage growth;
- the risk that we and our agency partners are unable to generate expected revenues or margins;
- risks associated with the insurance brokerage industry, including carrier concentration, regulation, competition, and cyclicality;
- the impact of economic conditions, inflation, and interest rate trends on our operations and customer demand;
- potential disruptions due to cybersecurity incidents or system failures;
- risks associated with legal proceedings and compliance obligations;
- and other risks and uncertainties described in this Quarterly Report on Form 10-Q, including under the section titled “Risk Factors,” and in our other filings with the Securities and Exchange Commission.

These forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q. Except as required by applicable law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

### Overview

Reliance Global Group, Inc. (the “Company”) operates as a diversified company engaging in business in the insurance market, as well as other related sectors. Our focus is to grow the Company by pursuing an aggressive acquisition strategy, initially and primarily focused upon wholesale and retail insurance agencies.

In the insurance sector, our management has extensive experience acquiring and managing insurance portfolios in several states, as well as developing specialized programs targeting niche markets. Our primary strategy is to identify specific risk to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows.

As part of our growth and acquisition strategy, we continue to survey the current insurance market for value-add acquisition opportunities. As of June 30, 2025, we had acquired nine insurance agencies.

Over the next 12 months, we plan to focus on the expansion and growth of our business through continued asset acquisitions in insurance markets and organic growth of our current insurance operations through geographic expansion and market share growth.

Further, we launched our 5MinuteInsure.com (“5MI”) Insurtech platform during 2021, which expanded our national footprint. 5MI is a high-tech proprietary tool developed by us as a business to consumer portal which enables consumers to instantly compare quotes from multiple carriers and purchase their car and home insurance in a time efficient and effective manner. 5MI taps into the growing number of online shoppers and utilizes advanced artificial intelligence and data mining techniques, to provide competitive insurance quotes in around 5 minutes with minimal data input needed from the consumer. The platform currently operates in 46 states offering coverage with up to 30 highly rated insurance carriers.

With the acquisition of Barra & Associates, LLC, we launched RELI Exchange, our business-to-business (“B2B”) InsurTech platform and agency partner network that builds on the artificial intelligence and data mining backbone of 5MinuteInsure.com. Through RELI Exchange we on-board agency partners and provide them with an InsurTech platform white labeled, designed and branded specifically for their business. This combines the best of digital and human capabilities by providing our agency partners and their customers quotes from multiple carriers within minutes. Since its inception, RELI Exchange has increased its agent roster by more than 300%.

### Business Operations

We’ve adopted a “OneFirm” strategy, pursuant to which Company owned and operated agencies come together to operate as one cohesive unit, which allows for efficient and effective cross-selling, cross-collaboration, and the effective deployment of the Company’s human capital. This strategy also aims to enhance the Company’s overall market presence across the U.S., with all business lines operating under the RELI Exchange brand. It’s expected to benefit agents and clients by improving relationships with carriers, leading to better commission and bonus contracts due to higher business volumes. The approach also strengthens the capability of RELI Exchange agency partners in securing diverse insurance policies and fosters increased cross-selling opportunities. This unified strategy positions the Company for rapid scaling and integration of accretive acquisitions, expanding its industry reach.

### Business Trends and Uncertainties

The insurance intermediary business is highly competitive, and we actively compete with numerous firms for customers and insurance companies, many of which have relationships with insurance companies, or have a significant presence in niche insurance markets that may give them an advantage over us. Other competitive concerns may include the quality of our products and services, our pricing and the ability of some of our customers to self-insure and the entrance of technology companies into the insurance intermediary business. Several insurance companies are engaged in the direct sale of insurance, primarily to individuals, and do not pay commissions to agents and brokers.

### Insurance Operations

Our insurance operations focus on the acquisition and management of insurance agencies throughout the U.S. Our primary focus is to pinpoint undervalued wholesale and retail insurance agencies with operations in growing or underserved segments (including healthcare and Medicare, as well as personal and commercial insurance lines). We then focus on expanding their operations on a national platform and improving operational efficiencies to achieve asset value appreciation while generating interim cash flows. In the insurance sector, our management team has over 100 years of experience acquiring and managing insurance portfolios in several states, as well as developing specialized programs targeting niche markets. We plan to accomplish these objectives by acquiring wholesale and retail insurance agencies it deems to represent a good buying opportunity (as opposed to insurance carriers) as insurance agencies bear no insurance risk. Once acquired, we plan to develop them on a national platform to increase revenues and profits through a synergetic structure. The Company is initially focused on segments that are underserved or growing, including healthcare and Medicare, as well as personal and commercial insurance lines.

### Insurance Acquisitions and Strategic Activities

As of June 30, 2025, we have acquired multiple insurance brokerages (see table below). As our acquisition strategy continues, our reach within the insurance arena can provide us with the ability to offer lower rates, which could boost our competitive position within the industry.

| Acquired | Reliance 100% Controlled Entity | Date | Location | Line of Business |
| --- | --- | --- | --- | --- |
| U.S. Benefits Alliance, LLC (USBA) | US Benefits Alliance, LLC | October 24, 2018 | Michigan | Health Insurance |
| Employee Benefit Solutions, LLC (EBS) | Employee Benefits Solutions, LLC | October 24, 2018 | Michigan | Health Insurance |
| Commercial Solutions of Insurance Agency, LLC (CCS or Commercial Solutions) | Commercial Coverage Solutions LLC | December 1, 2018 | New Jersey | P&C – Trucking Industry |
| Southwestern Montana Insurance Center, Inc. (Southwestern Montana or Montana) | Southwestern Montana Insurance Center, LLC | April 1, 2019 | Montana | Group Health Insurance |
| Fortman Insurance Agency, LLC (Fortman or Fortman Insurance) | Fortman Insurance Services, LLC | May 1, 2019 | Ohio | P&C and Health Insurance |
| Altruis Benefits Consultants, Inc. (Altruis) | Altruis Benefits Corporation | September 1, 2019 | Michigan | Health Insurance |
| UIS Agency, LLC (UIS) | UIS Agency, LLC | August 17, 2020 | New York | P&C – Trucking Industry |
| J.P. Kush and Associates, Inc. (Kush) | Kush Benefit Solutions, LLC | May 1, 2021 | Michigan | Health Insurance |
| Barra & Associates, LLC | RELI Exchange, LLC | April 26, 2022 | Illinois | P&C and Health Insurance |

20

### Recent Developments

### Series J

### Private Placement

On June 18, 2025, the Company entered into a securities purchase agreement with one institutional buyer for the purchase and sale of, of (i) pre-funded warrants (the “Series J-PF Warrants”) to purchase up to 1,488,096 shares of the Company’s Common Stock at an exercise price of $0.001 per share, and (ii) warrants (the “Series J Warrants”) to purchase up to 2,976,192 shares of Common Stock at an exercise price of $1.43 per share. The Private Placement-2025 was priced at the market at a combined purchase price per share and accompanying Series J Warrant of $1.68. Additionally, the Company issued a warrant to the Placement Agent (the “Series J PAW’s”), to acquire 104,167 shares of Common Stock at an exercise price of $2.10. The closing of the Private Placement occurred on June 20, 2025.

### Fortman Sale and Assets/Liabilities Held for Sale

On July 7, 2025, the Company, Fortman Insurance Services, LLC, an Ohio limited liability company and wholly owned subsidiary of the Company (the “Seller” or “Fortman”), and Fortman Insurance Agency, LLC, an Ohio limited liability company (the “Purchaser”), entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”), pursuant to which the Seller agreed to sell substantially all of the assets of its insurance agency business (the “Fortman Business”) to the Purchaser for aggregate cash consideration of $5,000,000 (the “Transaction”). The Transaction closed on July 7, 2025, and was effective as of 12:01 a.m. Eastern Time on July 1, 2025.

The assets sold pursuant to the Asset Purchase Agreement included the Seller’s book of business, accounts, rights to renewal commissions and entitlements arising from new or renewal insurance business after July 1, 2025 (the “Effective Date”), as well as associated goodwill, leasehold interests, intellectual property (including the Fortman Insurance Services and Fortman Insurance Agency names), and other tangible and intangible assets used in the Fortman Business, and certain liabilities were assumed by the Purchaser. The Transaction excluded, among other things, Seller’s pre-Effective Date cash and cash equivalents, and other specified excluded assets and liabilities.

Pursuant to the foregoing, during the second quarter of 2025, the Company committed to a plan to sell the asset group associated with Fortman as part of its strategy to monetize certain assets to focus and grow its core operations and pay-off its long-term debt. The disposal group met the criteria to be classified as held for sale under ASC 360-10-45 during the quarter ended, June 30, 2025, but did not qualify as a discontinued operation under ASC 205-20, as it does not represent a strategic shift that has or will have a major effect on the Company’s operations or financial results.

The assets and liabilities of the disposal group have been separately presented on the June 30, 2025, condensed consolidated balance sheet, as current assets held for sale and current liabilities related to assets held for sale. The assets held for sale account includes accounts receivable, prepaid expenses, property and equipment, intangibles, right of use assets and goodwill. Depreciation and amortization (when material) ceased on long-lived assets within the group effective on the classification date. The liabilities related to assets held for sale account includes the disposal group’s accounts payable and operating lease liabilities. No assets or liabilities were classified as held for sale as of December 31, 2024.

The Company measured the held for sale disposal group at the lower of, carrying value (“CV”), and fair value less costs to sell (“FV”), and determined that FV exceeded CV, thus there was no impairment charge. The Company expects to recognize a gain on sale during the third quarter of 2025, in an estimated amount of $2.99 million.

The following table summarizes the major classes of assets and liabilities classified as held for sale as of June 30, 2025:

|  | June 30, 2025 |
| --- | ---: |
| Accounts receivable | 142,324 |
| Other receivables | 32,229 |
| Prepaids and other current assets | 6,895 |
| Property and equipment, net | 14,864 |
| Right-of-use assets | 257,599 |
| Intangibles, net | 714,400 |
| Goodwill | 1,131,456 |
| Assets held for sale | 2,299,767 |
| Accounts payable and other accrued liabilities | 29,662 |
| Operating lease liabilities | 260,070 |
| Liabilities related to assets held for sale | 289,732 |

21

### Oak Street Debt Payments

During July 2025, the Company repaid $4,997,292 of its Oak Street long-term debt. These pre-payments were funded through proceeds from the asset sale of Fortman and did not incur any pre-payment penalties. The remaining outstanding long-term Oak Street loan balance after posting these pre-payments, net of debt issuance costs, was $5,374,461.

### Termination of the Spetner Agreement

On July 22, 2025, the Company accepted written notice from Spetner Associates, Inc. (“Spetner”), terminating the Stock Exchange Agreement, dated as of May 14, 2024, and as amended on September 6, 2024, October 29, 2024, and February 20, 2025 (collectively, the “Stock Exchange Agreement”). There are no material relationships between the Company and the Spetner Parties other than in respect of the Stock Exchange Agreement.

On October 29, 2024, and February 20, 2025, the Company issued 140,064 shares and 157,000 shares of its common stock to the Spetner sellers, representing non-refundable prepayments of approximately $329,430 and $239,425, respectively, as partial consideration for the contemplated acquisition. These were initially recorded by the Company in the prepaid expense and other current assets account on the consolidated balance sheets as of December 31, 2024, and March 31, 2025, respectively. However, pursuant to the termination of the Stock Exchange Agreement, the Company does not expect to recover these shares issued and thus has expensed them to the general and administrative account in the condensed consolidated statements of operations for the period ended, June 30 2025.

### Non-GAAP Financial Measure

The Company believes certain financial measures which meet the definition of non-GAAP financial measures, as defined in Regulation G of the SEC rules, provide important supplemental information. Adjusted EBITDA (“AEBITDA”), our key financial performance metric, is a non-GAAP financial measure that is not in accordance with, or an alternative to, measures prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”). “AEBITDA” is defined as earnings before interest, taxes, depreciation, and amortization (EBITDA) with additional adjustments as further outlined below. The Company considers AEBITDA an important financial metric because it provides a meaningful financial measure of the quality of the Company’s operational, cash impacted and recurring earnings and operating performance across reporting periods. Other companies may calculate Adjusted EBITDA differently than we do, which might limit its usefulness as a comparative measure to other companies in the industry. AEBITDA is used by management in addition to and in conjunction (and not as a substitute) with the results presented in accordance with GAAP. Management uses AEBITDA to evaluate the Company’s operational performance, including earnings across reporting periods and the merits for implementing cost-cutting measures. We have presented AEBITDA solely as supplemental disclosure because we believe it allows for a more complete analysis of results of operations and assists investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Consistent with Regulation G, a description of such information is provided below herein and tabular reconciliations of this supplemental non-GAAP financial information to our most comparable GAAP information are contained in this Quarterly Report on Form 10-Q under “Results of Operations”.

We exclude the following items when calculating AEBITDA, and the following items define our non-GAAP financial measure AEBITDA:

- Interest and related party interest expense: Unrelated to core Company operations and excluded to provide more meaningful supplemental information regarding the Company’s core operational performance.
- Depreciation and amortization: Non-cash charge, excluded to provide more meaningful supplemental information regarding the Company’s core operational performance.
- Goodwill and/or asset impairments: Non-cash charge, excluded to provide more meaningful supplemental information regarding the Company’s core operational performance.
- Equity-based compensation: Non-cash compensation provided to employees and service providers, excluded to provide more meaningful supplemental information regarding the Company’s core cash impacted operational performance.
- Change in estimated acquisition earn-out payables: An earn-out liability is a liability to the seller upon an acquisition which is contingent on future earnings. These liabilities are valued at each reporting period and the changes are reported as either a gain or loss in the change in estimated acquisition earn-out payables account in the consolidated statements of operations. The gain or loss is non-cash, can be highly volatile and overall is not deemed relevant to ongoing operations, thus, it’s excluded to provide more meaningful supplemental information regarding the Company’s core operational performance.
- Recognition and change in fair value of warrant liabilities: This account includes changes to derivative warrant liabilities which are valued at each reporting period and could result in either a gain or loss. The period changes do not impact cash, can be highly volatile, and are unrelated to ongoing operations, and thus are excluded to provide more meaningful supplemental information regarding the Company’s core operational performance.
- Other income (expense), net: Includes certain non-routine income or expenses and other individually de minimis items and is thus excluded as unrelated to core operations of the company.
- Transactional costs: This includes expenses related to mergers, acquisitions, financings and refinancings, and amendments or modification to indebtedness. These costs are unrelated to primary Company operations and are excluded to provide more meaningful supplemental information regarding the Company’s core operational performance.
- Non-standard costs: This account includes non-recurring non-operational items, related to costs incurred for a legal suit the Company has filed against one of the third parties involved in previously discontinued operations and was excluded to provide more meaningful supplemental information regarding the Company’s core operational performance.

Refer to the reconciliation of net (loss) income to AEBITDA, illustrated below in tabular format.

### Results of Operations

### CONSOLIDATED STATEMENTS OF OPERATIONS ANALYTICS

### Comparison of the three months ended June 30, 2025 to the three months ended June 30, 2024

|  | Three Months Ended June 30, 2025 | June 30, 2024 | Value Fluctuation | Percent Fluctuation | Explanations |
| --- | ---: | ---: | ---: | ---: | --- |
| Commission Income (“CI”) | $3,086,677 | $3,233,342 | $(146,665) | -5% | CI change primarily driven by 8% lower medical commission revenues, offset by 8% growth in P&C revenues. |
| Commission Expense (“CE”) | 988,774 | 886,364 | 102,410 | 12% | Increased CE primarily influenced by the 8% growth in P&C revenue. |
| Salaries and wages (“S&W”) | 2,563,519 | 1,955,152 | 608,367 | 31% | Increased S&W primarily due to non-cash share-based compensation offset by OneFirm efficiencies and overall leaner operations. |
| General and administrative expenses (“G&A”) | 1,492,839 | 991,633 | 501,206 | 51% | Increased G&A substantially driven by acquisition related cash and non-cash costs offset by OneFirm efficiencies and overall leaner operations. |
| Marketing and advertising expenses (“M&A”) | 67,207 | 76,983 | (9,776) | -13% | M&A decrease consistent with Company’s current marketing strategy. |
| Depreciation and amortization (“D&A”) | 346,151 | 469,788 | (123,637) | -26% | Decrease pursuant to passage of time as assets become fully amortized. |
| Total operating expenses | 5,458,490 | 4,379,920 | 1,078,570 | 25% |  |
|  |  |  | - |  |  |
| Loss from operations | (2,371,813) | (1,146,578) | (1,225,235) | 107% |  |
|  |  |  | - |  |  |
| Other income (expense) |  |  | - |  |  |
| Interest expense | (297,642) | (365,970) | 68,328 | -19% | Decrease per periodic paydowns on loan balances |
| Interest (expense) related parties | (21,346) | (37,525) | 16,179 | -43% | Decrease per periodic paydowns on loan balances |
| Other income (expense), net | (20,100) | 11 | (20,111) | -182827% | Decrease pursuant to other non-operating miscellaneous expenditures. |
| Recognition and change in fair value of warrant liabilities | - | 60,667 | (60,667) | -100% | Decrease pursuant to the settlement of all material derivative warrant liabilities. |
| Total other (expense) income | (339,088) | (342,817) | 3,729 | -1% |  |
| Net loss | (2,710,901) | (1,489,395) | (1,221,506) | 82% |  |
| Non-GAAP Measure |  |  |  |  |  |
| AEBITDA | (381,690) | (177,966) | (203,724) | 114% | Primarily lower due to fluctuations discussed above in the revenue and commission expense accounts offset by improvements in other expense accounts. |

24

### Comparison of the six months ended June 30, 2025 to the six months ended June 30, 2024

|  | Six Months Ended June 30, 2025 | June 30, 2024 | Value Fluctuation | Percent Fluctuation | Explanations |
| --- | ---: | ---: | ---: | ---: | --- |
| Commission Income (“CI”) | $7,322,897 | $7,315,780 | $7,117 | 0% | CI flat, primarily driven by 4% lower medical commission revenues, offset by 18% growth in P&C revenues. |
| Commission Expense (“CE”) | 2,458,202 | 2,162,905 | 295,297 | 14% | Increased CE primarily influenced by the 18% growth in P&C revenue as well as general market related increased commission rates. |
| Salaries and wages (“S&W”) | 4,793,357 | 3,786,814 | 1,006,543 | 27% | Increased S&W primarily due to non-cash share-based compensation offset by OneFirm efficiencies and overall leaner operations. |
| General and administrative expenses (“G&A”) | 3,009,067 | 2,366,523 | 642,544 | 27% | Increased G&A substantially driven by acquisition related cash and non-cash costs as well as non-cash share-based payments, offset by OneFirm efficiencies and overall leaner operations. |
| Marketing and advertising expenses (“M&A”) | 134,483 | 204,025 | (69,542) | -34% | M&A decrease consistent with Company’s current marketing strategy |
| Change in estimated acquisition earn-out payables | - | 47,761 | (47,761) | -100% | Decrease pursuant to the settlement of earn-out payables. |
| Depreciation and amortization (“D&A”) | 706,746 | 1,003,941 | (297,195) | -30% | Decrease pursuant to passage of time as assets become fully amortized, as well as impaired intangible assets no longer incurring D&A. |
| Asset impairment | - | 3,922,110 | (3,922,110) | -100% | No impaired assets during the current period. |
| Total operating expenses | 11,101,855 | 13,494,079 | (2,392,224) | -18% |  |
|  |  |  | - |  |  |
| Loss from operations | (3,778,958) | (6,178,299) | 2,399,341 | -39% |  |
|  |  |  | - |  |  |
| Other income (expense) |  |  | - |  |  |
| Interest expense | (598,124) | (735,646) | 137,522 | -19% | Decrease per periodic paydowns on loan balances |
| Interest (expense) related parties | (46,106) | (78,134) | 32,028 | -41% | Decrease per periodic paydowns on loan balances |
| Other income (expense), net | (24,598) | 22 | (24,620) | -111909% | Decrease pursuant to other non-operating miscellaneous expenditures. |
| Recognition and change in fair value of warrant liabilities | - | 156,000 | (156,000) | -100% | Fluctuation per fair value changes in derivative warrant liabilities. |
| Total other (expense) income | (668,828) | (657,758) | (11,070) | 2% |  |
| Loss from continuing operations before tax | (4,447,786) | (6,836,057) | 2,388,271 | -35% | Fluctuation explained on an account basis above. |
| Non-GAAP Measure |  |  |  |  |  |
| AEBITDA | (211,688) | (251,620) | 39,932 | -16% | Improved AEBITDA results primarily due to OneFirm efficiencies and overall leaner operations. |

25

### Non-GAAP Reconciliation from Net Loss to AEBITDA

The following table provides a reconciliation from net income (loss) to AEBITDA for the periods ended June 30, 2025 and June 30, 2024

|  | The Period Ended June 30, 2025 | 2024 | Six Months Ended June 30, 2025 | 2024 |
| --- | ---: | ---: | ---: | ---: |
| Net income (loss) | (2,710,901) | (1,489,395) | (4,447,786) | (6,836,057) |
| Adjustments: |  |  |  |  |
| Interest and related party interest expense | 318,988 | 403,495 | 644,230 | 813,780 |
| Depreciation and amortization | 346,151 | 469,788 | 706,746 | 1,003,941 |
| Asset impairment | - | - | - | 3,922,110 |
| Goodwill Impairment | - | - |  |  |
| Share based compensation employees directors and third parties | 1,479,557 | 333,897 | 2,504,542 | 488,808 |
| Change in estimated acquisition earn-out payables | - | - | - | 47,761 |
| Other (income) expense, net | - | (11) | 24,598 | (22) |
| Transactional costs | 248,049 | 119,203 | 391,236 | 373,096 |
| Non-standard costs | (63,534) | 45,724 | (35,254) | 90,963 |
| Recognition and change in fair value of warrant liabilities | - | (60,667) | - | (156,000) |
| Total adjustments | 2,329,211 | 1,311,429 | 4,236,098 | 6,584,437 |
| AEBITDA | (381,690) | (177,966) | (211,688) | (251,620) |

### Liquidity and capital resources

As of June 30, 2025, we had a cash balance of approximately $3,375,000 and working capital of approximately $2,089,000, compared with a cash balance of approximately $1,798,000 and working capital of approximately $416,000 at December 31, 2024.

On June 18, 2025, the Company entered into a securities purchase agreement (the “SPA-2025”) with a certain accredited investor (the “SPA Purchaser”) for the issuance and sale in a private placement (the “Private Placement-2025”) of (i) pre-funded warrants (the “Series J-PF Warrants”) to purchase up to 1,488,096 shares of the Company’s Common Stock at an exercise price of $0.001 per share, and (ii) warrants (the “Series J Warrants”) to purchase up to 2,976,192 shares of Common Stock at an exercise price of $1.43 per share. The Private Placement-2025 was priced at the market at a combined purchase price per share and accompanying Series J Warrant of $1.68. The closing of the Private Placement-2025 occurred on or about June 20, 2025.

Aggregate gross proceeds to the Company from the Private Placement-2025 were approximately $2.5 million, prior to deducting placement agent fees and other offering expenses payable by the Company, estimated at around $351,000, which resulted in estimated net proceeds of $2.15 million. The Company would receive an additional approximate $4.25 million in aggregate gross proceeds if all of the Series J Warrants were exercised via a cash exercise.

### Inflation

The Company generally may be impacted by rising costs for certain inflation-sensitive operating expenses such as labor, employee benefits, and facility leases. The Company believes inflation could have a material impact on pricing and operating expenses in future periods due to the state of the economy and current inflation rates.

### Off-balance sheet arrangements

We did not have any off-balance sheet arrangements, as such term is defined in Regulation S-K, during the six months ended June 30, 2025.

### Cash Flows

|  | Six Months Ended June 30, 2025 | 2024 |
| --- | ---: | ---: |
| Net cash used in operating activities | $(654,681) | (889,594) |
| Net cash (used in) provided by investing activities | (27,137) | (36,531) |
| Net cash provided by financing activities | 2,259,335 | 1,002,825 |
| Net increase in cash, cash equivalents, and restricted cash | $1,577,517 | $76,700 |

26

### Operating Activities

Net cash used in operating activities for the six months ended June 30, 2025, was approximately $655,000, compared to net cash flows used in operating activities of approximately $890,000 for the six months ended June 30, 2024. The cash used includes a net loss of approximately $4,448,000, decreased by approximate non-cash adjustments of $3,224,000 related to depreciation and amortization of approximately $707,000, share based compensation of approximately $2,505,000, and amortization of debt costs and non cash lease expense of approximately $13,000 as well as a net increase in cash due to changes of net working capital items of approximately $569,000.

### Investing Activities

During the six months ended June 30, 2025, cash flows used in investing activities approximated $27,000 compared to cash flows used by investing activities of approximately $36,500 for the six months ended June 30, 2024. The cash used during the six months ended June 30, 2025 is primarily related to the purchase of fixed tangible and intangible assets.

### Financing Activities

During the six months ended June 30, 2025, approximate cash provided by financing activities was $2.3 million, as compared to approximately $1.0 million for the six months ended June 30, 2024. Net cash provided by financing activities during the six months ended June 30, 2025, relates to proceeds from related party loans payable of approximately $1.1 million and from private placement offerings of approximately 2.1 million, offset by debt principal, short-term financings, and related party payables repayments of approximately $1.0 million.

### Significant Accounting Policies and Estimates

We describe our significant accounting policies in Note 2, *Summary of Significant Accounting Policies*, of the Notes to Consolidated Financial Statements, and our critical accounting estimates in Item 7, *Management’s Discussion and Analysis of Financial Condition and Results of Operations*, in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. There have been no significant changes in our significant accounting policies or critical accounting estimates since the end of fiscal year 2024.

## Controls and procedures

As filed, 1,734 characters.

### Evaluation of Disclosure Controls and Procedures

The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), refers to controls and procedures that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that such information is accumulated and communicated to a company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Our Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2025, and determined them to be effective as of June 30, 2025.

### Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 522 characters.

Investing in our common stock involves a high degree of risk. You should consider carefully the information disclosed in Part I, Item 1A, “Risk Factors,” contained in our Annual Report on Form 10-K for the year ended December 31, 2024, as the same may be updated from time to time. As a smaller reporting company, the Company is not required to disclose material changes to the risk factors that were contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, as updated from time to time.

Filed Jul 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-021555. Last ingested by Listed: Nov 10, 2026, 04:28 ET. No prices; not investment advice.
